Growth masked by an inventory echo; H2 should clear the air
Revenue grew 15% but profit fell 47%, courtesy of high-cost raw material inventory bought at the peak and expensed in Q2. The real story sits in the half-year numbers and October's recovery signal.
₹13.4 Cr
-47.0% YoY
₹56.2 Cr
+7.4% YoY
₹358.8 Cr
+15.0% YoY
The Q2 result lands with a puzzle: revenue climbs 15% year-on-year, a solid beat on industry growth, yet profit crashes 47%. The headline reads like a stumble. The call explains what happened — and why it wasn't.
The inventory echo
Indigo has been caught in a raw material price wave. In March–April 2026, crude spiked and paint feedstocks soared; the company bought inventory at the peak. That high-cost stock sat in the books and got expensed into Q2 COGS, depressing gross margin by 660 basis points. Management calls it 'the quirk of accountancy' — and it's real, not phantom. But it masks the operational picture. Q1 enjoyed the reverse phenomenon: low-cost inventory from before the spike got expensed into Q1 COGS, inflating EBITDA +42% year-on-year. Q2 hit the inverse. Together, H1 tells a steadier story: EBITDA margin 13.4%, down 170 bps, with PAT up 7.4% year-on-year. That's the organic run.
Margin breakdown: where the 660 bps fell
Management's claims, graded
Gross margin collapse is entirely inventory accounting, not operational failure.
Supported. Inventory accounts ~400 bps of 660 bps; mix is the remainder.
Q2 stand-alone revenue +14.1% YoY; industry grew 12–14%.
Supported. Consolidated +15% per delivered results; marginal outperformance.
October 2026 saw record monthly sales and highest Y-on-Y growth in 3–4 years.
Unverified. Stated post-Q2 close (Nov 2). Not in Q2 results; early signal of H2 recovery.
Jodhpur 90KL water-based plant fully operational by end-November 2026.
Supported on timeline. Trial started late Sept; target end-Nov. Minor fuzziness acknowledged.
No profitability shocks expected Q3 onwards; inventory is behind us.
Overstated. Contingent on crude $110–115 stability. Management: 'If crude goes through the roof, I can't predict.'
What changed on this call
The inventory burden is now explicit (prior call was vague). August already showed margin recovery as high-cost stock cleared; October's record sales claim—highest monthly Y-on-Y growth in 3–4 years—is a tangible early signal of H2 momentum. Guidance stance unchanged: no formal FY27 revenue target (prior call set the same tone), aggressive growth with accepted margin compression. Hemant Jalan continues dodging numeric targets ('I hesitate to give a number'), citing past over-commitment and current macro uncertainty. It's learning-and-caution, but also a guardrail on execution confidence.
Revenue +15% YoY, outpacing industry 12–14%
PAT -47% is inventory accounting shock, not operational failure
H1 EBITDA margin (13.4%, -170 bps) cleaner than Q2 in isolation
October record sales signal H2 momentum emerging
Jodhpur 90KL plant eliminates capex risk for 3 years
Dealer network (19,730) and reach (28 states, 6 plants) are structural
Price hikes (Nov 1 + Nov 21) risk volume elasticity in weak season
Geopolitical crude risk could repeat Q2-style margin shock
Management avoids numeric guidance; execution caution
Local competitors recovering ground (management's own words)
Risks, ranked by concern to a holder
Geopolitical crude spike (>$120)
HighUnhedgeable. Repeat of March–April surge loads high-cost inventory into Q3 books and repeats margin shock. Management flagged as 'beyond control.' Crude now $110–115 stable, but Middle East escalation is known risk.
Volume elasticity to stacked price hikes
MediumTwo price hikes in Nov (+10–12% total from March) test demand inelasticity at scale for first time. Paint 55%), so theory says demand inelastic. But 2–3 yrs price stability means behavior is unproven. Off-season (Nov–Dec) is wrong time to test.
Jodhpur plant execution delay
MediumTrial late Sept, target end-Nov full ops. Automation is complex; timeline fuzzy ('may happen 10–15 days earlier'). Even 2–3 week delay pushes Q3 contribution to Q4, and Q3 margin recovery leans on Jodhpur not adding cost.
Monsoon product mix overhang extends
MediumQ2 weakness in exterior paints (higher margin) due to monsoon. Management expects recovery in Q3 (festive season), but if monsoon extends or mix stays emulsion-heavy (lower margin), headwind persists into Q3.
Margin recovery contingent on macro, not just ops
MediumH2 guidance explicitly hedged on 'crude $110–115' and 'no geopolitical flare-up.' Conditional outlook, not commitment. Removes confidence if macro shifts.
Inventory accounting volatility repeats
Low-MediumIf raw material prices spike again, new high-cost inventory creates another swing in future quarters. Swing is real (COGS), but masks operational trends. Investors need to normalize for this.
How the street is positioned
The stock trades at ₹900.45, down sharply from its all-time high of ₹3,329.95 (drawdown of 73%). It sits below key moving averages: ₹992.95 (20-day), ₹1,069.14 (50-day), ₹999.32 (200-day). RSI is 31.7 (neutral). Volume is rising, signaling either capitulation or emerging interest. On ownership, FII have been net sellers: down 1.68 pp to 5.73% in Q1 FY27 (from 7.41% in Q4 FY26). DII have added: +2.25 pp to 25.25%. Promoters hold steady at 53.88%. On Aug 14, HDFC Mutual Fund bulk-bought 5,80,947 shares at ₹1,173.26 — a vote of confidence at prices well above today. The drawdown is steep; the valuation reset harsh. Q2 miss (-47% PAT) has driven FII exit; October recovery narrative hasn't yet anchored rebound. If H2 proves the recovery story, the valuation gap vs. historic multiples could trigger re-entry for institutions.
What to watch next
1 · Jodhpur plant: full operational status by end-Nov
Confirm 90KL plant running at intended capacity and margin-positive. Any delay or sub-capacity performance weakens H2 narrative. Track automation debugging daily for real-time progress.
2 · Margin recovery in Q3 (Oct–Dec festive quarter)
Look for EBITDA margin to expand materially from Q2 (8.6%) toward mid-teens. Driver: inventory clearing (done by Aug per mgmt), price-hike pass-through (Nov hikes), and mix recovery (festive season stronger in interior/premium). Flag October–November sales if disclosed.
3 · Crude oil forward: watch for spike toward $120+
If crude breaks $120, expect raw material re-acceleration and repeat high-cost inventory loading in Q3. $110–115 hold is green light; any jump is yellow flag for margin volatility.
Indigo Paints Q2 is a steady quarter hit by a temporary inventory timing shock. The company is not broken; it is in a margin compression cycle driven by raw material volatility and a deliberate strategy to pursue aggressive growth via price hikes and distribution. October's record sales claim, if sustained, validates H2 recovery. The real test is November and December: do price hikes hold volumes, does Jodhpur ramp as promised, and does crude stay stable? If all three check, the street's FII exit will look premature by Q3. If not, the case swings bear. The number to track from here is H2 EBITDA margin; hold mid-teens (15%+), and the thesis works. Miss it, and the debate reopens.
Informational and educational content only. Not investment advice.